GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mani Inc (TSE:7730) » Definitions » EBIT

Mani (TSE:7730) EBIT : 円9,001 Mil (TTM As of Feb. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Mani EBIT?

Mani's earnings before interest and taxes (EBIT) for the three months ended in Feb. 2024 was 円2,203 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Feb. 2024 was 円9,001 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Mani's annualized ROC % for the quarter that ended in Feb. 2024 was 19.16%. Mani's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2024 was 33.71%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Mani's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2024 was 5.65%.


Mani EBIT Historical Data

The historical data trend for Mani's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mani EBIT Chart

Mani Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,399.26 4,833.00 6,002.00 7,421.00 8,020.00

Mani Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,770.00 2,241.00 2,210.00 2,347.00 2,203.00

Competitive Comparison of Mani's EBIT

For the Medical Instruments & Supplies subindustry, Mani's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mani's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mani's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Mani's EV-to-EBIT falls into.



Mani EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円9,001 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mani  (TSE:7730) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Mani's annualized ROC % for the quarter that ended in Feb. 2024 is calculated as:

ROC % (Q: Feb. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Nov. 2023 ) + Invested Capital (Q: Feb. 2024 ))/ count )
=7896 * ( 1 - 26.55% )/( (29998 + 30547)/ 2 )
=5799.612/30272.5
=19.16 %

where

Note: The Operating Income data used here is four times the quarterly (Feb. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Mani's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Feb. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Nov. 2023  Q: Feb. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=8812/( ( (20470 + max(5158, 0)) + (20667 + max(5979, 0)) )/ 2 )
=8812/( ( 25628 + 26646 )/ 2 )
=8812/26137
=33.71 %

where Working Capital is:

Working Capital(Q: Nov. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2380 + 6382 + 688) - (2259 + 0 + 2033)
=5158

Working Capital(Q: Feb. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2474 + 6535 + 572) - (2089 + 0 + 1513)
=5979

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Feb. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Mani's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Feb. 2024 )
=9001/159368.617
=5.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mani EBIT Related Terms

Thank you for viewing the detailed overview of Mani's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Mani (TSE:7730) Business Description

Traded in Other Exchanges
N/A
Address
8-3 Kogyodanchi, Tochigi, JPN
Mani, Inc. manufactures medical devices and dental instruments. It sells products in four categories: surgical instruments, ophthalmic instruments, suture needles, and dental instruments. Mani's surgical products include instruments such as staplers, vessel knives, and bone saws. Its ophthalmic instruments include a range of knives used during eye surgery and ophthalmic sutures. Mani's suture needles business includes a variety of taper point and cutting eyeless needles, which require suture attachment and sterilization by the customer, as well as stainless-steel eyed needles. The firm's dental instruments include endodontic instruments and accessories, root canal equipment, and finishing and polishing instruments.

Mani (TSE:7730) Headlines

No Headlines